Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @ZymeComms
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @ZymeComms
-
.
@StartCodon today announced it has joined the@CR_UK Entrepreneurial Programmes Initiative, which aims to promote the development of new business ventures within academia and encourage entrepreneurship. https://bit.ly/3bbPTBT#accelerator#cambridgepic.twitter.com/7T6q7XYkl7
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Zyme Communications proslijedio/la je Tweet
1 in 2 of us will get cancer in our lifetimes. We are Owlstone Medical & we are developing a
#breathalyzer for disease. Our#BreathBiopsy platform is investigating new approaches for#earlydetection of cancer on breath http://bit.ly/2SbCIZa#WorldCancerDay
#WCD2020
#IAmAndIWill
pic.twitter.com/0kvfHOPT4c
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Enjoying the
@LSX World Congress in London today, hearing about new deals and partnerships across#biotech,#medtech and#healthcare facilitated at the event#LSXWorldpic.twitter.com/k0nf2KSUKY
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Zyme Communications proslijedio/la je Tweet
To mark World Cancer Day here is an interesting read on how “Cancer and rare diseases dominated 2019 drug approvals” Raising awareness of cancer and encouraging its prevention, detection, and treatment. http://chemistryworld.com/news/cancer-and-rare-diseases-dominated-2019-drug-approvals/4011105.article#/ …
#worldcancerday
#prevention#detection#treatmentHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
.
@nativeantigen, one of the world’s leading suppliers of reagents that enables research into#vaccines and diagnostics for emerging and endemic#infectiousdiseases, today announced the commercial release of its liquid format conjugation kits: http://bit.ly/2vGB9uz pic.twitter.com/Y6LlNShAda
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Zyme Communications proslijedio/la je Tweet
#Lungcancer is the most common cause of cancer death worldwide. Our team are committed to developing the best possible treatment for difficult tumours, together we will fight back against this awful disease#WorldCancerDay
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Zyme Communications proslijedio/la je Tweet
Did you know 1 in 2 people in the UK will be diagnosed with cancer in their lifetime? At Start Codon, we are committed to empowering
#oncology researchers and transforming pioneering science into life-saving therapies: http://bit.ly/2GOMGdE#WorldCancerDay
pic.twitter.com/ZlKlPwoGz3
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Zyme Communications proslijedio/la je Tweet
Researchers at
@UZH_Science have used imaging mass cytometry to simultaneously quantify 35 biomarkers, resulting in high-dimensional pathology images of tumor tissue from 352 patients with#breastcancer. Published in@nature - https://go.nature.com/396wgcE#WorldCancerDay
#Oncologypic.twitter.com/tBNIQracMi
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Open Pharma Research Ltd today announced the introduction of the
@LabOfTheFuture Congress USA, 19-20 May in#Boston, showcasing innovation in the#lifesciences. This follows the inaugural European#LaboftheFutureCongress last year. Find out more: http://bit.ly/2UlQ9bN pic.twitter.com/kcjphbwASD
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
.
@PhoreMostLtd today announced the appointments of Dr Catherine Beech OBE as Non-Executive Director and Dr Benedict Cross as Senior Director (Technology) https://bit.ly/2uXbtJR pic.twitter.com/4m9umuCn7g
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
.
@camscience launched its 2020 programme last week, this year exploring visions of the future. From mini organs in#biomedicine to life on Mars, it looks set to be interesting. We're glad to be based in a lively city for science! http://bit.ly/36ehSxh#CambridgeScienceFestivalpic.twitter.com/lwXMrUS9pG
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
.
@hel_group today announced the strengthening of production and customer service support for its scientific instrumentation and software, appointing Roy Eggleston, Tony Heywood, and John Forbes to its senior team: http://bit.ly/2O63wc3 pic.twitter.com/CaojlfSIr4
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
.
@Mogrify_UK today announced that it has secured $1.1M of additional funding from@sbrihealthcare to assess its regenerative#cartilage therapy before entering clinical trials https://bit.ly/311jz02#osteoarthritis#regenerativemedicinepic.twitter.com/RHNNbRbT7U
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
.
@avacta today announced that it has demonstrated initial proof-of-concept for its proprietary new class of drug conjugate, TMAC, in a pre-clinical animal model of cancer. The study showed that AVA04-VbP outperformed Bavencio, a marketed immunotherapy. https://avacta.com/successful-initial-proof-of-concept-for-a-proprietary-new-class-of-anti-cancer-therapy/ …pic.twitter.com/ZdSraIkfax
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our Managing Director Lorna Cuddon will be attending the
@LSX World Congress in#London on the 4-5 February. Follow the link below to learn more about the#healthcare and#lifescience companies showcasing their work to#investors and partners: http://bit.ly/2ugLRHB#LSXWorldpic.twitter.com/lBqxVnqCzh
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
What makes
#science and#healthcare clusters like#Cambridge,#Oxford and#Manchester so successful? Read this analysis from@localgoveditors for insight on how the growth of science hubs is shaping the UK's economy and geography: http://bit.ly/361ZlEs pic.twitter.com/xeVJccBt8v
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Zyme Communications proslijedio/la je Tweet
On this week's Careers in Discovery podcast, we were delighted to welcome
@DarrinMDisley, CEO of@Mogrify_UK, entrepreneur, investor, and advisor to over 40 companies. Go to https://anchor.fm/careers-in-discovery … to hear Darrin's unique journey and his principles for success. Enjoy!#podcastspic.twitter.com/yxQ7ujKOWv
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
.
@HZDiscovery today announced that it will license its GS knockout K1 cell line to@NGMBio to support the research and development of#biotherapeutics across multiple disease areas https://bit.ly/2RhUquV pic.twitter.com/N38jXS3hey
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
From advances in
#CRISPR and#AI to the growing concerns over#climatechange, the 2010s were a decade of rapid change. Check out the#science stories that shaped the past 10 years from@nature: https://go.nature.com/2FUKaCm pic.twitter.com/CvXWzMCLTr
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
.
@PhoreMostLtd today announced a new multi-project#drugdiscovery collaboration with Otsuka Pharmaceutical, with an initial focus on#genetherapy applications https://bit.ly/37kCFRi pic.twitter.com/r9RIAkuKBs
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.